CoChat

Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence

Demelash, Abeba, Pfannenstiel, Lukas W., Liu, Li, Gastman, Brian R. · 2017 · Oncotarget
Cited by 28

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.15962

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 61

  1. Ligon, 2010, The landscape of somatic copy-number alteration across human cancers, Nature, 463, 899, 10.1038/nature08822 · DOI · Paper page
  2. Campone, 2013, Decoding and unlocking the BCL-2 dependency of cancer cells, Nat Rev Cancer, 13, 455, 10.1038/nrc3538 · DOI · Paper page
  3. Huang, 2005, Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function, Mol Cell, 17, 393, 10.1016/j.molcel.2004.12.030 · DOI · Paper page
  4. Billard, 2013, BH3 mimetics: status of the field and new developments, Mol Cancer Ther, 12, 1691, 10.1158/1535-7163.MCT-13-0058 · DOI · Paper page
  5. Opferman, 2012, Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration, Nat Cell Biol, 14, 575, 10.1038/ncb2488 · DOI · Paper page
  6. Golub, 2012, Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency, Cancer Cell, 21, 547, 10.1016/j.ccr.2012.02.028 · DOI · Paper page
  7. Pellecchia, 2011, Identification of a novel Mcl-1 protein binding motif, J Biol Chem, 286, 39829, 10.1074/jbc.M111.305326 · DOI · Paper page
  8. Gastman, 2012, Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance, Mol Cell Biol, 32, 1879, 10.1128/MCB.06214-11 · DOI · Paper page
  9. Gastman, 2015, Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain, J Biol Chem, 290, 21962, 10.1074/jbc.M115.663898 · DOI · Paper page
  10. Korsmeyer, 1993, Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell, 75, 241, 10.1016/0092-8674(93)80066-N · DOI · Paper page
  11. De Pol, 2014, Nuclear Nox4-derived reactive oxygen species in myelodysplastic syndromes, Biomed Res Int, 2014, 456937
  12. Duronio, 2010, MCL-1 localizes to sites of DNA damage and regulates DNA damage response, Cell Cycle, 9, 2843
  13. Letai, 2008, Diagnosing and exploiting cancer’s addiction to blocks in apoptosis, Nat Rev Cancer, 8, 121, 10.1038/nrc2297 · DOI · Paper page
  14. Sattler, 2008, Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications, Antioxid Redox Signal, 10, 1813, 10.1089/ars.2008.2071 · DOI · Paper page
  15. Hirata, 1999, Redox regulation of cellular signalling, Cell Signal, 11, 1, 10.1016/S0898-6568(98)00037-0 · DOI · Paper page
  16. Huang, 2009, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nat Rev Drug Discov, 8, 579, 10.1038/nrd2803 · DOI · Paper page
  17. Thompson, 2000, Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis, Mol Cell Biol, 20, 5680, 10.1128/MCB.20.15.5680-5689.2000 · DOI · Paper page
  18. McIntyre, 2012, Oxidatively truncated phospholipids are required agents of tumor necrosis factor alpha (TNFalpha)-induced apoptosis, J Biol Chem, 287, 17693, 10.1074/jbc.M111.300012 · DOI
  19. Abboud, 2009, Subcellular localization of Nox4 and regulation in diabetes, Proc Natl Acad Sci USA, 106, 14385, 10.1073/pnas.0906805106 · DOI · Paper page
  20. Singh, 2010, NADPH oxidase 4 is an oncoprotein localized to mitochondria, Cancer Biol Ther, 10, 223, 10.4161/cbt.10.3.12207 · DOI · Paper page
  21. Fabregat, 2014, The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression, Free Radic Biol Med, 69, 338, 10.1016/j.freeradbiomed.2014.01.040 · DOI
  22. Fabregat, 2009, Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4, Cancer Res, 69, 7595, 10.1158/0008-5472.CAN-09-1482 · DOI
  23. Roberts, Davids, Pagel, Kahl, Puvvada, Gerecitano, Kipps, Anderson, Brown, Gressick, Wong, Dunbar, Zhu, et al. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. 2015. · DOI · Paper page
  24. Zhu, 2016, Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia, N Engl J Med, 374, 311, 10.1056/NEJMoa1513257 · DOI · Paper page
  25. McKeegan, 2012, Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer, Clin Cancer Res, 18, 3163, 10.1158/1078-0432.CCR-11-3090 · DOI · Paper page
  26. Lam, 2015, Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer, Mol Cancer, 14, 126, 10.1186/s12943-015-0397-y · DOI · Paper page
  27. Leverson, 2015, Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199), Blood Cancer J, 5, e368, 10.1038/bcj.2015.88 · DOI
  28. Korsmeyer, 1993, Bcl-2 heterodimerizeswith a conserved homolog, Bax, that accelerates programmed cell death, Cell, 74, 609, 10.1016/0092-8674(93)90509-O · DOI · Paper page
  29. Xu, 2013, A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia, Cancer Gene Ther, 20, 1, 10.1038/cgt.2012.84 · DOI
  30. Gastman, 2011, Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy, Clin Cancer Res, 17, 4975, 10.1158/1078-0432.CCR-10-3328 · DOI
  31. Li, 2011, Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis, Cell Death Differ, 18, 38, 10.1038/cdd.2010.68 · DOI · Paper page
  32. Gillet, 2013, Non-apoptotic roles of Bcl-2 family: the calcium connection, Biochim Biophys Acta, 1833, 1755, 10.1016/j.bbamcr.2013.01.021 · DOI
  33. Levine, 2005, Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy, Cell, 122, 927, 10.1016/j.cell.2005.07.002 · DOI · Paper page
  34. Duronio, 2008, An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation, Mol Biol Cell, 19, 3212, 10.1091/mbc.e07-11-1171 · DOI
  35. Mak, 2013, Modulation of oxidative stress as an anticancer strategy, Nat Rev Drug Discov, 12, 931, 10.1038/nrd4002 · DOI · Paper page
  36. Paolini, 2015, Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells, J Immunol, 195, 736, 10.4049/jimmunol.1402643 · DOI · Paper page
  37. Vaughan, 2016, A small molecule inhibitor of PAI-1 protects against Doxorubicin-induced cellular senescence: molecular basis, Oncotarget, 7, 72443, 10.18632/oncotarget.12494 · DOI · Paper page
  38. Deng, Kornblau, Ruvolo, May. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance. J Natl Cancer Inst Monogr. 2001; pp. 30–37. · DOI
  39. Pervaiz, 2015, Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide, Oncotarget, 6, 34191, 10.18632/oncotarget.5763 · DOI
  40. Pollack, 2013, Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage, Mol Carcinog, 52, 118, 10.1002/mc.21835 · DOI
  41. Bredesen, 1996, Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2, J Neurochem, 67, 1259, 10.1046/j.1471-4159.1996.67031259.x · DOI · Paper page
  42. Troppmair, 2013, RAF and antioxidants prevent cell death induction after growth factor abrogation through regulation of Bcl-2 proteins, Exp Cell Res, 319, 2728, 10.1016/j.yexcr.2013.07.029 · DOI
  43. Bignami, 2008, Overexpression of human NOX1 complex induces genome instability in mammalian cells, Free Radic Biol Med, 44, 332, 10.1016/j.freeradbiomed.2007.09.018 · DOI
  44. Doroshow, 2014, NADPH oxidases: a perspective on reactive oxygen species production in tumor biology, Antioxid Redox Signal, 20, 2873, 10.1089/ars.2013.5603 · DOI · Paper page
  45. Krause, 2007, The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology, Physiol Rev, 87, 245, 10.1152/physrev.00044.2005 · DOI · Paper page
  46. Brookes, 2013, Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel, Biochim Biophys Acta, 1827, 598, 10.1016/j.bbabio.2012.12.007 · DOI · Paper page
  47. Boveris, 1980, Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria, Biochem J, 191, 421, 10.1042/bj1910421 · DOI · Paper page
  48. Brandt, 1999, Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH: ubiquinone oxidoreductase), J Biol Chem, 274, 2625, 10.1074/jbc.274.5.2625 · DOI · Paper page
  49. Doroshow, 1986, Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase, J Biol Chem, 261, 3060, 10.1016/S0021-9258(17)35747-2 · DOI · Paper page
  50. Weiss, 1992, The anthracyclines: will we ever find a better doxorubicin?, Semin Oncol, 19, 670
  51. Young, 1996, Anthracycline-induced cardiotoxicity, Ann Intern Med, 125, 47, 10.7326/0003-4819-125-1-199607010-00008 · DOI · Paper page
  52. Schroder, 2010, NADPH oxidases in cardiovascular disease, Free Radic Biol Med, 49, 687, 10.1016/j.freeradbiomed.2010.04.030 · DOI · Paper page
  53. Leto, 2000, Identification of renox, an NAD(P)H oxidase in kidney, Proc Natl Acad Sci USA, 97, 8010, 10.1073/pnas.130135897 · DOI · Paper page
  54. Sumimoto, 2001, A novel superoxide-producing NAD(P)H oxidase in kidney, J Biol Chem, 276, 1417, 10.1074/jbc.M007597200 · DOI · Paper page
  55. Rossi, 2013, Doxorubicin induces senescence and impairs function of human cardiac progenitor cells, Basic Res Cardiol, 108, 334, 10.1007/s00395-013-0334-4 · DOI · Paper page
  56. Opferman, 2013, Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction, Genes Dev, 27, 1351, 10.1101/gad.215855.113 · DOI · Paper page
  57. Gustafsson, 2013, Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure, Genes Dev, 27, 1365, 10.1101/gad.215871.113 · DOI · Paper page
  58. Wu, 2011, Intracellular zinc release-activated ERK-dependent GSK-3beta-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury, Cell Death Differ, 18, 1651, 10.1038/cdd.2011.80 · DOI
  59. Wallace, 2008, MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: coordinate regulation of OXPHOS, antioxidant, and apoptotic genes, Biochim Biophys Acta, 1777, 666, 10.1016/j.bbabio.2008.03.015 · DOI
  60. Schumacker, 2014, Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?, Nat Rev Cancer, 14, 709, 10.1038/nrc3803 · DOI · Paper page
  61. Campisi, 1995, A biomarker that identifies senescent human cells in culture and in aging skin, Proc Natl Acad Sci USA, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page

Cited by

See all 28

Metadata

Authors
Demelash, A., Pfannenstiel, L. W., Liu, L., & Gastman, B. R.
Venue
Oncotarget
Published
2017-03-07
Volume
8
Issue
17
Pages
28154-28168
ISSN
1949-2553
Cited by
28
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.